HIV-1MN Recombinant Glycoprotein 160 Vaccine-Induced Cellular and Humoral Immunity Boosted by HIV-1MN Recombinant Glycoprotein 120 Vaccine-Reference-Cited by-同舟云学术

HIV-1MN Recombinant Glycoprotein 160 Vaccine-Induced Cellular and Humoral Immunity Boosted by HIV-1MN Recombinant Glycoprotein 120 Vaccine

Published:1999-01-20 Issue:2 Volume:15 Page:115-132
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Gorse Geoffrey J.,Corey Lawrence,Patel Gira B.,Mandava Mahendra,Hsieh Ray-Hahn,Matthews Thomas J.,Walker Mary Clare,Mcelrath M. Julie,Berman Phillip W.,Eibl Martha M.,Belshe Robert B.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/088922299311547

Reference60 articles.

1. The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

2. Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

3. Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans

4. Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection

5. HIV-1 recombinant gp160 vaccine given in accelerated dose schedules

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine delivery systems for immunization;Novel Formulations and Future Trends;2024

2. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response;PLOS Pathogens;2023-05-31

3. Impact of T h 1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques;Journal of Virology;2020-02-28

4. DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial;Journal of Clinical Investigation;2019-09-30

5. HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees;Journal of Virology;2018-04-15